and Launches Tender Offer for HISAMITSU

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on February 3, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

and Launches Tender Offer for HISAMITSU PHARMACEUTICAL CO.,INC. at undisclosed

Source disclosure: February 03, 2026 HISAMITSU PHARMACEUTICAL CO.,INC. [4530.T] TOKYO, Feb 3 (Reuters) - Taiyo Kobo Co., Ltd. announced today that it has submitted an amended tender offer filing to the Commissioner of the Tokyo Regional Finance Bureau regarding its public tender offer for Hisamitsu Pharmaceutical Co., Inc.'s common shares, subscription rights, and depositary receipts. The original tender offer was initially filed on January 7, 2026, and subsequently corrected on Janu